Ep. 6 | Eye-trackers: Novel Technology for Concussions & Brain Health Research

This episode of Talk Polymath discusses novel technologies for brain health and how eye movement can be used to diagnose and treat concussions. The guests will share the science behind their concussion diagnostic tool, the data that drives it, and how they see the future of brain health. Our guests are Rosina Samadani, Ph.D., CEO of Oculogica, and Dr. Uzma Samadani, M.D., Ph.D., Founder of Oculogica, Associate Professor, Department of Bioinformatics and Computational Biology at the University of Minnesota, and attending neurosurgeon at the Minneapolis Veterans Administration Medical Center.
Dr. Rosina Samadani has 20 years of experience with medical device companies, including 7 years with McKinsey & Company as a leader in their healthcare practice. This is her 4th startup. Dr. Samadani has her BS and MS from MIT in Mechanical Engineering, and her Ph.D. in Biomedical Engineering from Northwestern University.
Linkedin | Twitter
Dr. Uzma Samadani founded Oculogica in 2013, and her laboratory has developed the eye-tracking methodology and published six papers on its utility. She is currently an Associate Professor in the Department of Bioinformatics and Computational Biology at the University of Minnesota with a graduate faculty appointment in Neuroscience. She is also an attending neurosurgeon at the Minneapolis Veterans Administration Medical Center. She serves on the Executive Committee of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Section on Neurotrauma and Critical Care.
Linkedin | Twitter
__________
Talk Polymath is Polyplexus.com's monthly podcast series which features evidence-based conversations and invites global science leaders to converse about topics in science, technology, engineering, the arts, and math. From public health to changing models and trends in technology, this podcast engages in current cultural interests across disciplines.
For more information visit www.polyplexus.com.